loading
Schlusskurs vom Vortag:
$2.45
Offen:
$2.45
24-Stunden-Volumen:
4,383
Relative Volume:
0.01
Marktkapitalisierung:
$3.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.46M
KGV:
-1.0292
EPS:
-2.4
Netto-Cashflow:
$-30.20M
1W Leistung:
+1.25%
1M Leistung:
+66.44%
6M Leistung:
+17.39%
1J Leistung:
-81.73%
1-Tages-Spanne:
Value
$2.40
$2.47
1-Wochen-Bereich:
Value
$2.32
$2.86
52-Wochen-Spanne:
Value
$1.3137
$14.20

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name
Firmenname
Alaunos Therapeutics Inc
Name
Telefon
(346) 355-4099
Name
Adresse
2617 BISSONNET ST, HOUSTON
Name
Mitarbeiter
1
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-12
Name
Neueste SEC-Einreichungen
Name
TCRT's Discussions on Twitter

Vergleichen Sie TCRT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TCRT
Alaunos Therapeutics Inc
2.47 3.76M 0 -36.46M -30.20M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.67 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.31 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
630.10 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
258.65 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.13 24.70B 3.81B -644.79M -669.77M -6.24

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-10-04 Fortgesetzt Wells Fargo Overweight

Alaunos Therapeutics Inc Aktie (TCRT) Neueste Nachrichten

pulisher
Apr 24, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Up 2.5% – Time to Buy? - Defense World

Apr 24, 2025
pulisher
Apr 18, 2025

Alaunos Therapeutics announces board member resignation - Investing.com Australia

Apr 18, 2025
pulisher
Apr 18, 2025

Alaunos Therapeutics announces board member resignation By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 16, 2025

Form 8-KCurrent report - ADVFN

Apr 16, 2025
pulisher
Apr 15, 2025

Alaunos Therapeutics Board Opts for Equity Compensation - TipRanks

Apr 15, 2025
pulisher
Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock - Investing.com

Apr 14, 2025
pulisher
Apr 04, 2025

Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 04, 2025
pulisher
Apr 04, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Down 12.5% in March - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025
pulisher
Mar 31, 2025

Alaunos Therapeutics Inc. (TCRT) reports earnings - qz.com

Mar 31, 2025
pulisher
Mar 27, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Shares Down 6.5% – Here’s What Happened - Defense World

Mar 27, 2025
pulisher
Jan 29, 2025

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - Pharmaceutical Technology

Jan 29, 2025
pulisher
Jan 15, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 4% – Should You Buy? - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Update: Johnson & Johnson acquires Intra-Cellular Therapies - Pharmaceutical Technology

Jan 13, 2025
pulisher
Jan 10, 2025

Light Horse emerges with $62m and Novartis partnership worth up to $1bn - Pharmaceutical Technology

Jan 10, 2025
pulisher
Dec 24, 2024

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Down 0.5% – Time to Sell? - Defense World

Dec 24, 2024
pulisher
Dec 13, 2024

TCRT stock touches 52-week low at $1.92 amid market challenges - Investing.com

Dec 13, 2024
pulisher
Nov 22, 2024

Novartis acquires Kate Therapeutics to advance gene therapies - Pharmaceutical Technology

Nov 22, 2024
pulisher
Nov 15, 2024

Alaunos Therapeutics Inc (TCRT) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Ziopharm: Q3 Earnings Snapshot - The Washington Post

Nov 14, 2024
pulisher
Nov 08, 2024

TCRT Stock Touches 52-Week Low at $1.96 Amid Market Challenges - Investing.com Nigeria

Nov 08, 2024
pulisher
Oct 28, 2024

TCRT stock touches 52-week low at $2.06 amid market challenges - Investing.com

Oct 28, 2024
pulisher
Oct 11, 2024

After axing its sole clinical prospect last year, Alaunos cuts ties with Precigen - Fierce Biotech

Oct 11, 2024
pulisher
Oct 10, 2024

Alaunos Therapeutics ends key agreement and updates on financial condition - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024
pulisher
Oct 01, 2024

Genentech buys Regor’s CDK inhibitors in $850m deal - Clinical Trials Arena

Oct 01, 2024
pulisher
Aug 23, 2024

VION Biosciences acquires Echelon Biosciences - Pharmaceutical Technology

Aug 23, 2024
pulisher
Aug 14, 2024

Eli Lilly inaugurates R&D facility in Boston, US - Pharmaceutical Technology

Aug 14, 2024
pulisher
Jul 16, 2024

Alaunos Therapeutics announces 1-for-10 reverse stock split - Investing.com

Jul 16, 2024
pulisher
Mar 27, 2024

Avenzo Therapeutics secures $150m to bolster oncology pipeline - Pharmaceutical Technology

Mar 27, 2024
pulisher
Mar 25, 2024

Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn - Pharmaceutical Technology

Mar 25, 2024
pulisher
Jan 30, 2024

Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks

Jan 30, 2024
pulisher
Jan 25, 2024

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Jan 25, 2024
pulisher
Jan 24, 2024

NAYA buys gene therapy company Florida Biotech for $20m - Clinical Trials Arena

Jan 24, 2024
pulisher
Jan 23, 2024

Genentech signs nanoparticle deal worth up to $644m with GenEdit - Pharmaceutical Technology

Jan 23, 2024
pulisher
Jan 04, 2024

BridGene and Galapagos partner for oncology drugs discovery - Pharmaceutical Technology

Jan 04, 2024
pulisher
Jan 03, 2024

Novartis allies with Voyager to develop gene therapies in $1.3bn deal - Pharmaceutical Technology

Jan 03, 2024
pulisher
Dec 18, 2023

Why Is Alaunos Therapeutics (TCRT) Stock Up 37% Today? - MSN

Dec 18, 2023
pulisher
Nov 23, 2023

Syncona to buy biotechnology company Freeline Therapeutics - Pharmaceutical Technology

Nov 23, 2023
pulisher
Nov 14, 2023

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - Yahoo Finance

Nov 14, 2023
pulisher
Nov 09, 2023

Ascidian Therapeutics raises $40m to advance drug development - Pharmaceutical Technology

Nov 09, 2023
pulisher
Nov 01, 2023

AstraZeneca and Cellectis partner to advance cell and gene therapies - Pharmaceutical Technology

Nov 01, 2023
pulisher
Oct 26, 2023

How gene therapies can transform sickle cell disease treatment - Pharmaceutical Technology

Oct 26, 2023
pulisher
Aug 17, 2023

StockWatch: Illumina Results Leave Investors, Analysts Anxious - Genetic Engineering and Biotechnology News

Aug 17, 2023
pulisher
Aug 16, 2023

Alaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65% - Nasdaq

Aug 16, 2023
pulisher
Aug 15, 2023

Houston biotech winds down sole clinical-stage trial, cuts 60% of staff - Fierce Biotech

Aug 15, 2023
pulisher
Jun 27, 2023

Houston BioTech Donation Enriches UH Program - University of Houston

Jun 27, 2023
pulisher
Jun 21, 2023

15 Biotech Stocks Wall Street Analysts Say Are Too Cheap - Barron's

Jun 21, 2023
pulisher
Jun 08, 2023

Hopewell Therapeutics raises funds for genomic medicines development - Pharmaceutical Technology

Jun 08, 2023

Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):